---
title: "BRAWLEY OTIS W — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75
json: https://whiteintel.dev/api/public/dossier/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75
identifier: sec:0001213029
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BRAWLEY OTIS W

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001213029`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75  

## Ownership & control

### Holdings / subsidiaries

- **AGILENT TECHNOLOGIES, INC.** (director) — https://whiteintel.dev/entity/cc12f8bc-d539-5aab-b0b9-ab20eb441ef8
- **Lyell Immunopharma, Inc.** (director) — https://whiteintel.dev/entity/eeb1283f-805a-5e39-98c5-0756afaf7715
- **INCYTE CORP** (director) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **PDS Biotechnology Corp** (director) — https://whiteintel.dev/entity/e2703dc3-b125-53f2-882e-5c573014d9ac
- **AGILENT TECHNOLOGIES, INC.** (director) — https://whiteintel.dev/entity/cc12f8bc-d539-5aab-b0b9-ab20eb441ef8
- **THERAGENICS CORP** (director) — https://whiteintel.dev/entity/4d20c850-a705-573e-b8e9-3ed7d27cae71

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BRAWLEY OTIS W**. Human view: https://whiteintel.dev/entity/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75 · Structured JSON: https://whiteintel.dev/api/public/dossier/d6b050b6-a23a-5bca-8005-e2dcc6c7cd75._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._